Lupus-like anticoagulant in pregnancy

Identification of novel cell survival regulation in diabetic embryopathy via phospholipidomic profiling.

Biochemical and biophysical research communications·2016

Decreased fetal cardiac performance in the first trimester correlates with hyperglycemia in pregestational maternal diabetes.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2011

At diabetes-like concentration, glucose down-regulates the placental serotonin transport system in a cell-cycle-dependent manner.

Journal of neurochemistry·2007

Self-monitoring of blood glucose in gestational diabetes.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2003

Blood glucose monitoring in gestational diabetes mellitus: 1- versus 2-h blood glucose determinations.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2003

Role of diltiazem in pregnant women with chronic renal disease.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2003

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Related Experiment Videos

Lupus-like anticoagulant in pregnancy

Related Concept Videos

Identification of novel cell survival regulation in diabetic embryopathy via phospholipidomic profiling.

Decreased fetal cardiac performance in the first trimester correlates with hyperglycemia in pregestational maternal diabetes.

At diabetes-like concentration, glucose down-regulates the placental serotonin transport system in a cell-cycle-dependent manner.

Self-monitoring of blood glucose in gestational diabetes.

Blood glucose monitoring in gestational diabetes mellitus: 1- versus 2-h blood glucose determinations.

Role of diltiazem in pregnant women with chronic renal disease.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Related Experiment Videos

Lupus-like anticoagulant in pregnancy

Related Concept Videos

Related Articles